Fig. 2From: Pharmacokinetic-pharmacodynamic modeling of tylosin against Streptococcus suis in pigsThe ex vivo antibacterial curve of tylosin against CVCC606 in serum from healthy pigs (a) and diseased pigs (b). The ex vivo antibacterial activity in serum was determined in samples harvested at pre-determined times (0.17, 0.33, 0.5, 1, 2, 3, 4, 6, 8, 10, 12Â h after tylosin IM dosing)Back to article page